The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for a new, lower dose of ALK-Abelló’s…
Read More
Prenatal Chlorpyrifos Exposure Linked to Lasting Brain Alterations and Reduced Motor Function in Children
A groundbreaking longitudinal study published in the peer-reviewed journal JAMA Neurology has provided the first definitive evidence that prenatal exposure…
Read More
Tanzanian Housing Design Significantly Reduces Malaria and Diarrhea in Children
A groundbreaking study conducted in Tanzania has revealed that specially designed housing, incorporating features such as insect screens, rainwater harvesting…
Read More
Expanding Screening for Type 1 Diabetes in Children Could Identify More Cases
A significant shift in the approach to identifying type 1 diabetes in children is being advocated for, with a new…
Read More
Prenatal Exposure to Chlorpyrifos Linked to Lasting Brain Alterations and Impaired Motor Development in Children and Adolescents
A landmark longitudinal study has established a definitive connection between prenatal exposure to the common organophosphate insecticide chlorpyrifos (CPF) and…
Read More
Labcorp and Children’s Hospital of Philadelphia Forge Alliance to Revolutionize Pediatric Diagnostics and Expand National Access
The landscape of clinical diagnostics is poised for a significant transformation following the announcement of a strategic collaboration between Labcorp,…
Read More
Labcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Revolutionize Pediatric Diagnostics and National Access
Labcorp, a leading global life sciences company, and the Children’s Hospital of Philadelphia (CHOP), a globally recognized leader in pediatric…
Read More
Labcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Advance Pediatric Diagnostics and National Access
Labcorp, a leading global life sciences company, and the Children’s Hospital of Philadelphia (CHOP), a preeminent pediatric research and clinical…
Read More
Sanofi Receives FDA Approval to Expand Tzield Use in Children as Young as One Year for Type 1 Diabetes Delay
Sanofi has secured a significant expansion of its U.S. Food and Drug Administration (FDA) approval for Tzield (teplizumab-mzwv), a groundbreaking…
Read More
New drug cuts seizures by up to 91% in children with rare epilepsy
In a landmark development for pediatric neurology, an international clinical trial has demonstrated that an experimental genetic therapy, zorevunersen, can…
Read MoreYOU MAY HAVE MISSED
